Recombinant Human KIF15 Protein, N-His

Introduction
Recombinant Human KIF15 Protein, also known as Kinesin Family Member 15, is a motor protein that plays a crucial role in cell division and mitosis. It is a member of the kinesin superfamily, which are microtubule-based motor proteins that are responsible for transporting cellular cargo and organizing the mitotic spindle during cell division. In this article, we will explore the structure, activity, and applications of Recombinant Human KIF15 Protein.

Structure of Recombinant Human KIF15 Protein
The human KIF15 gene is located on chromosome 1 and encodes a protein of 1,335 amino acids. The protein consists of several domains, including an N-terminal motor domain, a central coiled-coil domain, and a C-terminal tail domain. The motor domain is responsible for the ATP-dependent movement of KIF15 along microtubules, while the coiled-coil domain allows for dimerization and interaction with other proteins. The tail domain is involved in cargo binding and regulation of KIF15 activity.

Activity of Recombinant Human KIF15 Protein
Recombinant Human KIF15 Protein is a microtubule-based motor protein that plays a crucial role in cell division and mitosis. During mitosis, KIF15 is responsible for organizing and stabilizing the mitotic spindle, which is essential for proper chromosome segregation. It achieves this by binding to and sliding along microtubules, using ATP hydrolysis to generate force and move cargo. KIF15 is also involved in cytokinesis, the final stage of cell division, by promoting the formation and constriction of the contractile ring.

Applications of Recombinant Human KIF15 Protein
1. Research in Cell Division and Mitosis
Recombinant Human KIF15 Protein has been widely used in research to understand the mechanisms of cell division and mitosis. By studying the structure and activity of KIF15, researchers can gain insights into its role in organizing the mitotic spindle and regulating chromosome segregation. This knowledge can help in the development of new therapies for diseases related to cell division, such as cancer.

2. Drug Target for Cancer Therapy
Abnormalities in KIF15 expression and function have been linked to various types of cancer, including breast, lung, and colon cancer. Therefore, Recombinant Human KIF15 Protein has been identified as a potential drug target for cancer therapy. By inhibiting the activity of KIF15, researchers hope to disrupt the proper functioning of the mitotic spindle and induce cell death in cancer cells.

3. Development of Antibodies and Vaccines
Recombinant Human KIF15 Protein has also been used to develop antibodies and vaccines against various diseases. The protein can be used as an antigen to stimulate the production of specific antibodies in the body, which can then be used for diagnostic and therapeutic purposes. Additionally, KIF15 has been identified as a potential target for vaccine development against parasitic diseases, such as malaria and trypanosomiasis.

4. Production of Recombinant Protein
Recombinant Human KIF15 Protein is also used in the production of other recombinant proteins. The protein can be expressed in various expression systems, such as bacteria, yeast, and mammalian cells, and used as a fusion partner to enhance the expression and solubility of target proteins. This is particularly useful in the production of difficult-to-express proteins, which are essential for research and therapeutic purposes.

Conclusion
Recombinant Human KIF15 Protein is a microtubule-based motor protein that plays a crucial role in cell division and mitosis. Its structure, activity, and applications have been extensively studied, and it has been identified as a potential drug target for cancer therapy and a key player in the development of antibodies and vaccines. Further research on this protein can lead to a better understanding of its role in cellular processes and the development of new therapies for diseases related to cell division.